Abstract
A growing body of literature indicates that chronic morphine exposure alters the expression and function of cytoskeletal proteins in addition to the well established interactions between μ opioid receptors and G proteins. In the present study, we hypothesized that chronic morphine alters the expression and functional effects of Gα12, a G protein that regulates downstream cytoskeletal proteins via its control of RhoA. Our results showed that chronic morphine treatment decreased the expression of Gαi2 (64%) and Gαi3 (60%), had no effect of Gαo, and increased Gα12 (66%) expression in Chinese hamster ovary (CHO) cells expressing the cloned human μ opioid receptors (hMOR-CHO cells) but not in cells expressing a mutant μ opioid receptor that do not develop morphine tolerance and dependence (T394A-CHO cells). Morphine treatment had no significant effect on PAR-1 thrombin receptor-activated G protein activity, as measured by thrombin-stimulated guanosine 5′-O-(3-[35S]thio)triphosphate binding. Chronic morphine treatment significantly enhanced thrombin-stimulated RhoA activity and thrombin-stimulated expression of α-actinin, a cytoskeletal anchoring protein, in hMOR-CHO cells. Proteomic analysis of two-dimensional gel spots prepared from hMOR-CHO cells showed that morphine treatment affected the expression of a number of proteins associated with morphological changes. Up-regulation of Gα12 and α-actinin by chronic morphine was also observed in mouse brain. Viewed collectively, these findings indicate, for the first time, that chronic morphine enhances the Gα12-associated signaling system, which is involved in regulating cellular morphology and growth, supporting other findings that chronic morphine may alter cellular morphology, in addition to cellular function.
Footnotes
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.105.089367.
-
ABBREVIATIONS: hMOR-CHO, CHO cells expressing the cloned human μ opioid receptor; CHO, chinese hamster ovary; T394A-CHO, CHO cells expressing the cloned mutant μ opioid receptor; PBS, phosphate-buffered saline; [35S]GTPγS, guanosine 5′-O-(3-[35S]thio)triphosphate; DAMGO, [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin; SA, specific activity; SPA, scintillation proximity assay; RBD, Rho-binding domain; 2D, two-dimensional; PAR-1, protease-activated receptor-1.
- Received May 10, 2005.
- Accepted June 22, 2005.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|